Examining the global softgel manufacturing equipment market, covering comprehensive solutions for pharmaceutical and nutraceutical production, key equipment types including encapsulation, drying, and inspection systems, and the future outlook for softgel production equipment through 2035.
The Global Softgel Manufacturing Equipment Market represents the comprehensive landscape of pharmaceutical and nutraceutical production innovations, providing the essential machinery that enables intelligent, high-performance, and reliable softgel capsule manufacturing through integrated systems of encapsulation machines, drying tunnels, inspection equipment, and packaging lines designed to produce gelatin and non-gelatin softgel capsules with precise fill weights, consistent seal integrity, and high production throughput for pharmaceutical, nutraceutical, cosmetic, and food supplement applications. According to comprehensive market analysis, the Global Softgel Manufacturing Equipment Market was valued at 4.57 billion USD in 2024 and is projected to reach 6.5 billion USD by 2035, growing at a CAGR of 3.2%, with Softgel Encapsulation Machines representing a critical component supporting next-generation drug delivery and nutritional supplement manufacturing where bioavailability, dosage precision, and production efficiency are increasingly important for product efficacy, patient compliance, and market competitiveness. The market is characterized by a growing emphasis on automation and technological advancements, with the Pharmaceuticals application commanding a predominant role, valued at 1.9 billion USD in 2024 and projected to reach 2.6 billion USD in 2035, due to the increasing demand for encapsulated medications and the growing trend of personalized medicine, while the integration of automation and smart manufacturing systems is transforming the softgel manufacturing equipment landscape. Key players in the market include Catalent, Inc., ACG Worldwide, KRG Healthcare, Lonza, and Qualicaps.
Softgel production equipment is essential for enabling effective, intelligent, and reliable pharmaceutical manufacturing, providing the critical machinery that powers the production of softgel capsules through sophisticated systems of encapsulation machines, drying equipment, inspection systems, and packaging lines that deliver enhanced production efficiency, consistent product quality, and operational reliability across diverse applications and regulatory requirements. The growing demand for softgel manufacturing equipment is a direct response to increasing demand for pharmaceutical products, technological advancements in manufacturing processes, and the rising popularity of dietary supplements, with the softgel manufacturing equipment market projected to grow at a compound annual growth rate of approximately 3.2% over the forecast period. The Pharmaceuticals application commands a predominant role, holding the majority share due to the increasing demand for encapsulated medications and the growing trend of personalized medicine, while the Nutraceuticals sector shows strong growth prospects as consumers increasingly prioritize health and wellness, leading to a steady expansion in the demand for dietary supplements and functional foods. The adoption of advanced Pharmaceutical Capsule Manufacturing solutions is becoming a standard practice for pharmaceutical and nutraceutical manufacturers, as they seek to optimize production efficiency, enhance product quality, and achieve superior manufacturing outcomes through modern softgel production technologies.
The global softgel manufacturing equipment market is currently experiencing significant transformation driven by automation integration and plant-based formulation trends. The integration of automation and smart manufacturing systems within softgel production is improving efficiency and reducing operational costs, with automated systems and intelligent manufacturing capabilities improving production efficiency and consistency, and artificial intelligence and robotics in operations leading to productivity increases of up to 40%. The notable shift towards the production of plant-based softgels is catering to the growing consumer preference for vegan and gluten-free products, reshaping equipment requirements and production techniques, with vegetable softgels appealing to the growing vegetarian population and offerings of plant-based products. In recent developments, Sanner Group announced a strategic partnership with Apex Manufacturing in February 2025 to co-develop high-throughput softgel encapsulation lines for pharmaceutical production, while Lonza announced the acquisition of Soft Gel Technologies' softgel encapsulation assets in March 2025 to expand its end-to-end softgel manufacturing capabilities, and Qualicaps introduced a next-generation automated softgel encapsulation platform in May 2025 with integrated inline quality control and analytics. The market is seeing increasing adoption of automated encapsulation systems for high-throughput production, development of plant-based softgel manufacturing capabilities to meet vegan and vegetarian demand, and integration of inline quality control and analytics for enhanced product quality and compliance.
The adoption of softgel manufacturing equipment is being driven by several factors, including pharmaceutical product demand, technological advancements, and dietary supplement popularity. The global demand for pharmaceutical products is witnessing significant growth, driven largely by an aging population and increased prevalence of chronic diseases, with the number of people aged 60 years or older expected to reach 2 billion by 2050, creating a subsequent demand for more effective drug formulations including softgel capsules, and stimulating innovations and investments in production technologies. Technological advancements in softgel manufacturing processes are significantly propelling market growth, with innovations such as automated systems and intelligent manufacturing capabilities improving production efficiency and consistency, reducing operational costs, and manufacturers integrating advanced technologies such as artificial intelligence and robotics seeing productivity increases of up to 40%. The global dietary supplements market is expanding rapidly, contributing to the increasing use of softgel capsules as a preferred delivery method, with the global dietary supplements market projected to reach USD 300 billion by 2025, and the appeal of softgels lying in their ability to mask unpleasant tastes and improve absorption rates compared to traditional tablets. By 2035, the market is expected to achieve steady growth driven by innovation and strategic investments, with new opportunities lying in the development of high-throughput automated encapsulation systems for pharmaceutical production, expansion into plant-based softgel manufacturing capabilities, and integration of inline quality control and analytics for enhanced product quality and compliance. As the industry continues to evolve, the global softgel manufacturing equipment market will continue its growth trajectory, supported by innovation and increasing recognition of Softgel Production Equipment as essential for pharmaceutical and nutraceutical production, product quality, and achieving superior manufacturing efficiency and patient outcomes
Gain a competitive edge with insightful market reports:
Spinning Flow Formed Wheels Market